Reversine promotes browning of white adipocytes by suppressing miR-133a

J Cell Physiol. 2019 Apr;234(4):3800-3813. doi: 10.1002/jcp.27148. Epub 2018 Aug 21.

Abstract

Brown adipocytes are characterized by a high number of uncoupling protein 1 (UCP1)-positive mitochondrial content and increased thermogenic capacity. As UCP1-enriched cells can consume lipids by generating heat, browning of white adipocytes is now highlighted as a promising approach for the prevention of obesity and obesity-associated metabolic diseases. Upon cold exposure or β-adrenergic stimuli, downregulation of microRNA-133 (miR-133) elevates the expression levels of PR domain containing 16 (Prdm16), which has been shown to be a brown adipose determination factor, in brown adipose tissue and subcutaneous white adipose tissues (WAT). Here, we show that treatment of reversine to white adipocytes induces browning via suppression of miR-133a. Reversine treatment promoted the expression of brown adipocyte marker genes, such as Prdm16 and UCP1, increasing the mitochondrial content, while decreasing the levels of miR-133a and white adipocyte marker genes. Ectopic expression of miR-133a mimic reversed the browning effects of the reversine treatment. Moreover, intraperitoneal administration of reversine in mice upregulated thermogenesis and resulted in resistance to high-fat diet-mediated weight gain as well as browning of subcutaneous and epididymal WAT. Taken together, we found a novel way to promote browning of white adipocytes through downregulation of miR-133a followed by activation of Prdm16, with a synthetic chemical, reversine.

Keywords: PR domain containing 16; adipocytes; browning; microRNA-133a; reversine; uncoupling protein 1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipocytes, White / drug effects*
  • Adipocytes, White / metabolism
  • Adipocytes, White / pathology
  • Adipose Tissue, Brown / drug effects*
  • Adipose Tissue, Brown / metabolism
  • Adipose Tissue, Brown / pathology
  • Animals
  • Anti-Obesity Agents / pharmacology*
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Diet, High-Fat
  • Disease Models, Animal
  • Down-Regulation
  • Male
  • Mice
  • Mice, Inbred C57BL
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Mitochondria / pathology
  • Morpholines / pharmacology*
  • Obesity / etiology
  • Obesity / metabolism
  • Obesity / pathology
  • Obesity / prevention & control*
  • Phenotype
  • Purines / pharmacology*
  • Signal Transduction
  • Thermogenesis / drug effects
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Uncoupling Protein 1 / genetics
  • Uncoupling Protein 1 / metabolism
  • Weight Gain / drug effects*

Substances

  • Anti-Obesity Agents
  • DNA-Binding Proteins
  • MicroRNAs
  • Mirn133 microRNA, mouse
  • Morpholines
  • Prdm16 protein, mouse
  • Purines
  • Transcription Factors
  • Ucp1 protein, mouse
  • Uncoupling Protein 1
  • 2-(4-morpholinoanilino)-6-cyclohexylaminopurine